NCT00365508 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 321
- group Id
- BG001
- value
- 321
- group Id
- BG002
- value
- 642
- units
- Participants
- groups
- description
- Participants apply a transdermal nicotine patch at 3 different time periods during weeks 3-14; a higher-dose patch is applied for weeks 3-8, a medium-dose patch is applied for weeks 9-10, and a lower-dose patch is applied for weeks 11-14.
- id
- BG000
- title
- Arm I
- description
- Participants receive one oral nicotine lozenge every 1-2 hours in weeks 3-8 (≥ 9 lozenges per day), one lozenge every 2-4 hours in weeks 9-11 (≥ 5 lozenges per day), and 1 lozenge every 4-8 hours in weeks 12-14 (≥ 3 lozenges per day).
- id
- BG001
- title
- Arm II
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.7
- value
- 44.7
- group Id
- BG001
- spread
- 11.9
- value
- 44.8
- group Id
- BG002
- spread
- 12.3
- value
- 44.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 195
- group Id
- BG001
- value
- 170
- group Id
- BG002
- value
- 365
- title
- Female
- measurements
- group Id
- BG000
- value
- 126
- group Id
- BG001
- value
- 151
- group Id
- BG002
- value
- 277
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 321
- group Id
- BG001
- value
- 321
- group Id
- BG002
- value
- 642
- units
- Participants
- groups
- description
- Participants apply a transdermal nicotine patch at 3 different time periods during weeks 3-14; a higher-dose patch is applied for weeks 3-8, a medium-dose patch is applied for weeks 9-10, and a lower-dose patch is applied for weeks 11-14.
- id
- BG000
- title
- Arm I
- description
- Participants receive one oral nicotine lozenge every 1-2 hours in weeks 3-8 (≥ 9 lozenges per day), one lozenge every 2-4 hours in weeks 9-11 (≥ 5 lozenges per day), and 1 lozenge every 4-8 hours in weeks 12-14 (≥ 3 lozenges per day).
- id
- BG001
- title
- Arm II
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.7
- value
- 44.7
- group Id
- BG001
- spread
- 11.9
- value
- 44.8
- group Id
- BG002
- spread
- 12.3
- value
- 44.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 195
- group Id
- BG001
- value
- 170
- group Id
- BG002
- value
- 365
- title
- Female
- measurements
- group Id
- BG000
- value
- 126
- group Id
- BG001
- value
- 151
- group Id
- BG002
- value
- 277
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle